Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Post by Solid1on May 23, 2024 3:25am

A quiz game

The first time it was mentioned in the Q3 2022 conference call that an NDA is in the works. Hey guys, let's have a little guessing game... what could the new NDA be?  I'll start, it' ...more  
Comment by alleyesonmeon May 22, 2024 7:39pm

RE:RE:RE:Investor attitude toward management

LOL!!!!   Read the CC transcript...read the MD&A...!!!!!! They 100% have a client partner who has "submitted" a NEW DRUG application..your motives are questionable, this is ...more  
Comment by QContinuum1on May 22, 2024 6:31pm

RE:RE:RE:Investor attitude toward management

The investor deck says a good many things, including having forward looking cautionary notes among other statements that can be used to explain that not all statements made are as you clearly take ...more  
Comment by alleyesonmeon May 22, 2024 4:20pm

RE:RE:Investor attitude toward management

It's on the investors deck MD&A and was mentioned on the last CC.  Do I believe what they say...yes I do...clearly they can't discuss more otherwise they would..this is a fact I ...more  
Comment by rusty777on May 22, 2024 3:44pm

RE:Investor attitude toward management

I think many of the investors here are well beyond frustrated.  For those who originally owned ABCANN which became VIVO, which was absorbed into Medipharm, we have seen management time and time ...more  
Comment by QContinuum1on May 22, 2024 2:20pm

RE:RE:Investor attitude toward management

If you believe they have a NDA independent of the ANDA with the FDA, why not ask the company for clarification on that one item?  It would be interesting to get their feedback on what submission ...more  
Comment by alleyesonmeon May 22, 2024 12:58pm

RE:Investor attitude toward management

The then what is enormous, new drug application most likely being held up due to the API being in schedule 1, I bet it's approved shortly after official change, furthermore FDA guidelines when ...more  
Post by Olaf123on May 22, 2024 11:07am

Investor attitude toward management

I understand investors frustration. Our investments have been with no reward for a number of years. However, I believe some of us have been unfair to management. Nonetheless, I respect candor in ...more  
Comment by QContinuum1on May 22, 2024 10:48am

RE:RE:lots of

My hopium brain thinks that the business is in a blackout period and that's the reason why the Q call and other docs are very light on detail. My rational brain tells me that if light details and ...more  
Comment by alleyesonmeon May 22, 2024 10:47am

RE:lots of

Insiders own just under 20%, thanks to the generous share based compensation plan, the only way they can buy or sell is through the pre-arranged trading plan, the name of this regulatory filing, can ...more  
Post by lscfaon May 22, 2024 10:21am

FDA Has Granted Innocan a Meeting Date for LPT-CBD for pain

  https://www.newswire.ca/news-releases/fda-has-granted-innocan-pharma-a-meeting-date-for-lpt-cbd-for-chronic-pain-828975778.html
Post by 1hot-techwomanon May 22, 2024 9:56am

Marijuana outpaces Alcohol in USA !!

https://www.msn.com/en-ca/news/world/daily-marijuana-use-outpaces-daily-drinking-in-the-us-a-new-study-says/ar-BB1mQITZ?ocid=hpmsn&cvid=303952c640524d3d8a76335f5ae38f28&ei=15 Only a metter ...more  
Comment by Solid1on May 22, 2024 9:55am

RE:lots of

Medipharm Labs is definitely sitting on information they are not yet allowed to disclose, which means they are not allowed to buy on the market either - that would be insider trading. If only because ...more  
Post by okgonowon May 22, 2024 9:22am

lots of

Insider buying going on in many of my other holdings wish Pidduck and the management at MPL would do a little themselves insted of just granting the options. Nothing says we believe in this company ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities